{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097680","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2023-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.238141+00:00","generated_at":"2026-06-07T08:46:54.019159+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"China Pharma acquires COPD drug patent for $1.65M in restricted stock; royalty of 15% net profit","bullets":["Subsidiary Helpson enters Technology Transfer Agreement with Tao Liu for a COPD drug combination patent.","Consideration: 15,000,000 restricted shares at $0.11/share ($1.65M) under Regulation S exemption.","Helpson to pay 15% of net profit from product sales annually for 10 years if product is profitable.","Transferor to provide R&D, registration, and technical services in Haikou.","Shares are unregistered and issued in an offshore transaction to a non-U.S. person."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097680","json":"https://secwatch.observer/filing/0001213900-23-097680.json","markdown":"https://secwatch.observer/filing/0001213900-23-097680.md","text":"https://secwatch.observer/filing/0001213900-23-097680.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/0001213900-23-097680-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/ea190499-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T08:46:54.019159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fb767793fd5b1efb90e98b4f541cf965a509f62d","claim":"CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Tao Liu valued at $1.65 million (effective 2023-12-15).","evidence_excerpt":"On December 15, 2023, Hainan Helpson Medical & Biotechnology Co., Ltd (“ Helpson ”), a wholly owned subsidiary of China Pharma Holdings, Inc. (the “ Company ”), entered into a Technology Transfer Agreement (the “ Agreement ”) with Tao Liu (the “ Transferor ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023097680/0001213900-23-097680-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Tao Liu"},{"label":"Value","value":"$1.65 million"},{"label":"Effective","value":"2023-12-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}